Anemia and Its Associated Factors Among Adult People Living with Human Immunodeficiency Virus at Wolaita Sodo University Teaching Referral Hospital

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2019 Oct 10

PMID 31596865

Citations 18

Authors

Temesgen Anjulo Ageru

Mengistu Meskele Koyra

Kassa Daka Gidebo

Temesgen Lera Abiso

Affiliations

Soon will be listed here.

Abstract

Background: In Sub-Saharan Africa, both HIV/AIDS and anemia have considerable public health problems. Anemia has an adverse effect on treatment outcome and it decreases the quality of life among adult HIV patients. This study was aimed to assess the prevalence of anemia and its associated factors among adult HIV positive patients in Wolaita Sodo University Teaching Referral Hospital.

Method: Institution based cross-sectional study was conducted at Wolaita Sodo University Teaching Referral Hospital from 01 October to December 30, 2016. A randomly selected 411 adult people living with the human immunodeficiency virus were included in the study. A pre-tested questionnaire was used to collect data. Variables with P-value ≤0.25 in the bivariable logistic regression model were taken into multivariable logistic regression analysis along with 95% confidence interval and Odds Ratio was used to examine the association between anemia and independent variables. P-value ≤ 0.05 was taken as statistically significant.

Result: Prevalence of anemia in this study was 36.5% with 95% CI (32%-41%). Factors associated with anemia among adult people living with HIV/AIDS were individuals who lived with HIV ≥9years (AOR = 2.6, 95% CI:-1.03-6.59),years lived with HIV 5-8 years (AOR = 2.59, 95% CI:-1.02-6.57),CD4 count <200cells/ul (AOR = 4.2, 95%CI:-2.03-8.67), CD4 count200-350cells/ul(AOR = 1.82,95%CI:-1.01-3.26),infection with intestinal parasites (AOR = 2.04, 95% CI:-1.06-3.95), Participants with BMI <18.5kg/m2 (AOR = 2.96, 95%CI:-1.37-6.390),BMI 18.5-25kg/m2(AOR = 1.98, 95%CI:-1.11-3.56) and being HAART naïve (AOR = 2.23, 95% CI:- 1.16-4.28).

Conclusion: Prevalence of anemia among this study participant was high. This may affect the treatment outcome, increases morbidity and mortality of the participants. So periodic screening of anemia, a routine checkup of nutritional status, CD4 count and examination for intestinal parasite are essential.

Citing Articles

Sex differences in the risk profiles for anemia in people living with HIV, A cross sectional study.

Kamvuma K, Hamooya B, Chiyenu K, Ademola Y, Mudenda S, Machiko A PLoS One. 2025; 20(3):e0319611.

PMID: 40063574 PMC: 11892841. DOI: 10.1371/journal.pone.0319611.

Incidence and Risk Factors of Zidovudine-Induced Anemia in Patients With HIV Infection Receiving Zidovudine-Containing Antiretroviral Therapy.

Boonyagars L, Thinpangnga P, Munsakul W J Int Assoc Provid AIDS Care. 2025; 24:23259582251321577.

PMID: 39967242 PMC: 11863231. DOI: 10.1177/23259582251321577.

Unveiling the prevalence of anaemia and its predictors among adults on highly active antiretroviral therapy in the dolutegravir era: a retrospective cross-sectional study.

Sisay Zewdu W, Molla Zeleke M, Ferede Y, Kassie A, Singh P, Alemu M BMJ Open. 2024; 14(9):e086480.

PMID: 39242159 PMC: 11590816. DOI: 10.1136/bmjopen-2024-086480.

Incidence and risk factors of anaemia among people on antiretroviral therapy in Harare.

Mandikiyana Chirimuta L, Shamu T, Chimbetete C, Part C South Afr J HIV Med. 2024; 25(1):1605.

PMID: 39228915 PMC: 11369551. DOI: 10.4102/sajhivmed.v25i1.1605.

Mechanisms and Cardiorenal Complications of Chronic Anemia in People with HIV.

Kamvuma K, Hamooya B, Munsaka S, Masenga S, Kirabo A Viruses. 2024; 16(4).

PMID: 38675885 PMC: 11053456. DOI: 10.3390/v16040542.

References

Enawgaw B, Alem M, Addis Z, Melku M . Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia:.... BMC Hematol. 2014; 14(1):8. PMC: 3994311. DOI: 10.1186/2052-1839-14-8. View

Reust C . Common adverse effects of antiretroviral therapy for HIV disease. Am Fam Physician. 2011; 83(12):1443-51. View

Opie J . Haematological complications of HIV infection. S Afr Med J. 2012; 102(6):465-8. DOI: 10.7196/samj.5595. View

Rehman A, Woodd S, PrayGod G, Chisenga M, Siame J, Koethe J . Effects on anthropometry and appetite of vitamins and minerals given in lipid nutritional supplements for malnourished HIV-infected adults referred for antiretroviral therapy: results from the NUSTART randomized controlled trial. J Acquir Immune Defic Syndr. 2014; 68(4):405-12. PMC: 4337586. DOI: 10.1097/QAI.0000000000000483. View

Fufa H, Umeta M, Taffesse S, Mokhtar N, Aguenaou H . Nutritional and immunological status and their associations among HIV-infected adults in Addis Ababa, Ethiopia. Food Nutr Bull. 2009; 30(3):227-32. DOI: 10.1177/156482650903000303. View

Owiredu W, Quaye L, Amidu N, Addai-Mensah O . Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011; 11(1):2-15. PMC: 3092327. View

Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-Kaloustian K, Maxwell N . Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. J Int AIDS Soc. 2012; 15(1):5. PMC: 3292983. DOI: 10.1186/1758-2652-15-5. View

Meidani M, Rezaei F, Maracy M, Avijgan M, Tayeri K . Prevalence, severity, and related factors of anemia in HIV/AIDS patients. J Res Med Sci. 2012; 17(2):138-42. PMC: 3525030. View

Filteau S, PrayGod G, Kasonka L, Woodd S, Rehman A, Chisenga M . Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial. BMC Med. 2015; 13:17. PMC: 4308881. DOI: 10.1186/s12916-014-0253-8. View

10.

Agarwal D, Chakravarty J, Chaube L, Rai M, Agrawal N, Sundar S . High incidence of zidovudine induced anaemia in HIV infected patients in eastern India. Indian J Med Res. 2010; 132:386-9. View

11.

Missaye A, Dagnew M, Alemu A, Alemu A . Prevalence of intestinal parasites and associated risk factors among HIV/AIDS patients with pre-ART and on-ART attending dessie hospital ART clinic, Northeast Ethiopia. AIDS Res Ther. 2013; 10(1):7. PMC: 3598834. DOI: 10.1186/1742-6405-10-7. View

12.

Sicotte M, Bemeur C, Diouf A, Zunzunegui M, Nguyen V . Nutritional status of HIV-infected patients during the first year HAART in two West African cohorts. J Health Popul Nutr. 2016; 34:1. PMC: 5026015. DOI: 10.1186/s41043-015-0001-5. View

13.

Johannessen A, Naman E, Gundersen S, Bruun J . Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis. 2011; 11:190. PMC: 3145581. DOI: 10.1186/1471-2334-11-190. View

14.

Mengist H, Taye B, Tsegaye A . Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia. PLoS One. 2015; 10(2):e0117715. PMC: 4320101. DOI: 10.1371/journal.pone.0117715. View

15.

Walson J, Stewart B, Sangare L, Mbogo L, Otieno P, Piper B . Prevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults. PLoS Negl Trop Dis. 2010; 4(3):e644. PMC: 2846937. DOI: 10.1371/journal.pntd.0000644. View

16.

de Santis G, Brunetta D, Vilar F, Brandao R, Muniz R, de Lima G . Hematological abnormalities in HIV-infected patients. Int J Infect Dis. 2011; 15(12):e808-11. DOI: 10.1016/j.ijid.2011.08.001. View

17.

Kerkhoff A, Wood R, Vogt M, Lawn S . Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays. J Acquir Immune Defic Syndr. 2013; 66(1):33-40. PMC: 3981888. DOI: 10.1097/QAI.0000000000000091. View

18.

Nagu T, Spiegelman D, Hertzmark E, Aboud S, Makani J, Matee M . Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania. PLoS One. 2014; 9(3):e91229. PMC: 3958362. DOI: 10.1371/journal.pone.0091229. View

19.

Assefa M, Abegaz W, Shewamare A, Medhin G, Belay M . Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. BMC Hematol. 2015; 15:6. PMC: 4455710. DOI: 10.1186/s12878-015-0024-6. View

20.

Kawai K, Villamor E, Mugusi F, Saathoff E, Urassa W, Bosch R . Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania. Int J Tuberc Lung Dis. 2012; 15(10):1380-9. PMC: 3404808. DOI: 10.5588/ijtld.10.0784. View